Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kristeleit, RS
32  Ergebnisse:
Personensuche X
?
1

Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib v..:

Banerjee, S ; Giannone, G ; Clamp, AR...
2802566.  , 2023
Link: https://repository.icr.a..
 
?
2

A randomized, phase III trial to evaluate rucaparib monothe..:

Monk, BJ ; Parkinson, C ; Lim, MC...
Journal of Clinical Oncology.  , 2022
Link: http://hdl.handle.net/10..
 
?
3

Molecular and clinical determinants of response and resista..:

Swisher, EM ; Kwan, TT ; Oza, AM...
Nature Communications.  , 2021
Link: http://hdl.handle.net/10..
 
?
4

Molecular and clinical determinants of response and resista..:

Swisher, EM ; Kwan, TT ; Oza, AM...
issn:2041-1723.  , 2021
Link: http://hdl.handle.net/11..
 
?
5

Population exposure-efficacy and exposure-safety analyses f..:

Konecny, GE ; Oza, AM ; Tinker, AV...
Gynecologic Oncology.  , 2021
Link: http://hdl.handle.net/10..
 
?
6

Real-World Delivery of Rucaparib to Patients with Ovarian C..:

Drew, Y ; Kristeleit, RS ; Oaknin, A...
https://discovery.ucl.ac.uk/id/eprint/10085804/1/Kristeleit_Real-World%20Delivery%20of%20Rucaparib%20to%20Patients%20with%20Ovarian%20Cancer_VoR.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
7

Phase I/IIa, open-label, multicentre study to evaluate the ..:

Bono, P ; Massard, C ; Peltola, KJ...
https://discovery.ucl.ac.uk/id/eprint/10117425/1/e001081.full.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
8

Antitumor activity of the poly(ADP-ribose) polymerase inhib..:

Kristeleit, RS ; Oaknin, A ; Ray-Coquard, I...
https://discovery.ucl.ac.uk/id/eprint/10086074/1/1396.full.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
9

Antitumor activity of the poly(ADP-ribose) polymerase inhib..:

Kristeleit, RS ; Oaknin, A ; Ray-Coquard, I...
International Journal of Gynecologic Cancer.  , 2019
Link: http://hdl.handle.net/10..
 
?
10

Pharmacokinetic Study of Rucaparib in Patients With Advance..:

Shapiro, GI ; Kristeleit, RS ; Burris, HA...
https://discovery.ucl.ac.uk/id/eprint/10049440/1/Kristeleit_Pharmacokinetic%20Study%20of%20Rucaparib%20in%20Patients%20with%20Advanced%20Solid%20Tumors_VoR.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
?
11

BRCA1 and RAD51C Promoter Hypermethylation Confer Sensitivi..:

Swisher, E ; Harrell, MI ; Lin, KK...
https://discovery.ucl.ac.uk/id/eprint/1559750/1/Kristeleit_Ovarian%20Carcinoma.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
12

A first-in-human Phase I/II, dose escalation, pharmacokinet..:

Kristeleit, RS ; Miller, R ; Sellers, L...
https://discovery.ucl.ac.uk/id/eprint/1553487/3/Kristeleit_A%20FIH%20trial%20of%20VAL-201.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
13

Outcome of patients with advanced endometrial and cervical ..:

Miller, R ; Devlin, M-J ; Brown, NF...
https://discovery.ucl.ac.uk/id/eprint/1574284/2/Forster_ASCO2017%20Phase%20I%20endometrial%20cervix.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
14

Rucaparib in relapsed, platinum-sensitive high-grade ovaria..:

Swisher, EM ; Lin, KK ; Oza, AM...
https://discovery.ucl.ac.uk/id/eprint/10049690/1/Kristeleit_ARIEL2_HRD_Manuscript_Lancet_Oncol_09Sep2016%28clean%29.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
15

988TiP: ARIEL4: An international, randomised phase 3 study ..:

Kristeleit, RS ; Lorusso, D ; Oaknin, A...
https://discovery.ucl.ac.uk/id/eprint/1574295/1/Kristeleit%20ESMO%202017%20ARIEL4%20TiP%20abstract_10May2017c.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
1-15